X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Aventis Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ADCOCK INGRAM (S. Africa) - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ADCOCK INGRAM
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ADCOCK INGRAM
Jun-14
SANOFI INDIA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs6,840351-   
Low Rs4,630253-   
Sales per share (Unadj.) Rs1,203.1104.4-  
Earnings per share (Unadj.) Rs165.3-26.3-  
Cash flow per share (Unadj.) Rs209.9-21.8-  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.681.9-  
Shares outstanding (eoy) m23.03168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.82.9 164.7%   
Avg P/E ratio x34.7-11.5 -302.2%  
P/CF ratio (eoy) x27.3-13.9 -197.2%  
Price / Book Value ratio x6.03.7 161.5%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,07850,974 259.1%   
No. of employees `0003.34.3 76.9%   
Total wages/salary Rs m4,0683,199 127.2%   
Avg. sales/employee Rs Th8,393.84,103.8 204.5%   
Avg. wages/employee Rs Th1,232.4745.2 165.4%   
Avg. net profit/employee Rs Th1,153.0-1,034.1 -111.5%   
INCOME DATA
Net Sales Rs m27,70817,618 157.3%  
Other income Rs m897123 727.1%   
Total revenues Rs m28,60517,741 161.2%   
Gross profit Rs m6,235-3,053 -204.2%  
Depreciation Rs m1,027760 135.1%   
Interest Rs m7477 1.5%   
Profit before tax Rs m6,098-4,167 -146.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292260 880.2%   
Profit after tax Rs m3,806-4,439 -85.7%  
Gross profit margin %22.5-17.3 -129.9%  
Effective tax rate %37.6-6.2 -601.5%   
Net profit margin %13.7-25.2 -54.5%  
BALANCE SHEET DATA
Current assets Rs m15,92212,903 123.4%   
Current liabilities Rs m6,2357,260 85.9%   
Net working cap to sales %35.032.0 109.1%  
Current ratio x2.61.8 143.7%  
Inventory Days Days64111 57.4%  
Debtors Days Days21124 16.8%  
Net fixed assets Rs m7,5397,521 100.2%   
Share capital Rs m23082 281.2%   
"Free" reserves Rs m21,9620-   
Net worth Rs m22,19213,828 160.5%   
Long term debt Rs m04,859 0.0%   
Total assets Rs m29,83926,122 114.2%  
Interest coverage x872.1-7.7 -11,279.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 137.7%   
Return on assets %12.8-15.2 -84.3%  
Return on equity %17.2-32.1 -53.4%  
Return on capital %27.5-19.8 -138.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4420-   
CASH FLOW
From Operations Rs m3,7391,504 248.6%  
From Investments Rs m-731-462 158.3%  
From Financial Activity Rs m-1,9724,410 -44.7%  
Net Cashflow Rs m1,0365,452 19.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.84 Rs / ZAR

Compare SANOFI INDIA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: DR. DATSONS LABS  TORRENT PHARMA  PFIZER  VENUS REMEDIES  BIOCON   



Today's Market

Sensex Ends 140 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets ended their day on a positive note today ahead of counting of Lok Sabha Election 2019 to be done tomorrow.

Related Views On News

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 22, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - FULFORD INDIA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS